South Africa: Concern Over HIV Drug Trial
A proposed trial of an old antiretroviral drug, stavudine, which is no longer recommended due to its side-effects, has raised concern among Aids activists who argue that its low cost is not enough reason to consider using it.
Receiving antiretroviral treatment.
The Independent, 20 August 2011
On Tuesdays, the Paediatric Ward at Mulago National Referral Hospital in Kampala is usually packed with young people from as early as 8am. Some stay glued to the big TV screen, ... read more »
PlusNews, 20 July 2011
Middle-income countries with large numbers of people living with HIV will no longer benefit from preferential pricing when buying antiretroviral drugs from large pharmaceutical ... read more »
The Nation, 28 June 2011
A class of HIV drugs common in Kenya has been found to cause premature aging and hasten heart and brain disorders. read more »
The Herald, 10 February 2011
THERE are some people who have been on ART for sometime now and had been doing well. read more »
HIV-positive people in South Africa will be able to access antiretroviral sooner after the government raised the CD4 count necessary to access treatment. But some warn the victory ... Read more »